Floatz logo

Therapeutic Asset Ratings

344 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Elotuzumab
Multiple Myeloma
Hoffmann-La RocheP3BB (64)
Gm-Csf
Multiple Myeloma
David AviganP3BB (64)
Anti-Bcma Car-T Cells
Multiple Myeloma
Thomas Martin, MDP3B (63)
Cevostamab
Multiple Myeloma
Hoffmann-La RocheP3B (63)
CM336
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (63)
Etentamig
Multiple Myeloma
Universitätsklinikum Hamburg-EppendorfP3B (63)
Iberdomide
Multiple Myeloma
Dana-Farber Cancer InstituteP3B (63)
Montelukast
Multiple Myeloma
Emory UniversityP4B (62)
Thiotepa
Multiple Myeloma
First Affiliated Hospital Xi'an Jiaotong UniversityP4B (62)
Cytosin-Arabinosid
Multiple Myeloma
The Affiliated People's Hospital of Ningbo UniversityP3B (62)
Daratumumab-Hyaluronidase
Multiple Myeloma
PrECOG, LLC.P3B (62)
Monomethyl Fumarate
Multiple Myeloma
Wondercel Biotech (ShenZhen)P3B (62)
RANITIDINE
Multiple Myeloma
Hoffmann-La RocheP3B (62)
Siltuximab
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, ChinaP3B (62)
bkt140
Multiple Myeloma
Guangzhou Gloria Biosciences Co., Ltd.P4B (61)
Cilta-Cel
Multiple Myeloma
Janssen Research & Development, LLCP4B (61)
Mesna
Multiple Myeloma
Indapta Therapeutics, INC.P4B (61)
Palifermin
Multiple Myeloma
City of Hope Medical CenterP4B (61)
Acetylsalicylic Acid
Multiple Myeloma
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyP3B (61)
Endoxan
Multiple Myeloma
Celyad Oncology SAP3B (61)
FLUDEOXYGLUCOSE
Multiple Myeloma
National Cancer Institute (NCI)P3B (61)
SULFAMETHOXAZOLE
Multiple Myeloma
Monash UniversityP3B (61)
Trimethoprim
Multiple Myeloma
Monash UniversityP3B (61)
Apixaban
Multiple Myeloma
Centre Hospitalier Universitaire de Saint EtienneP4B (60)
Conjugated Pneumococcal Vaccine
Multiple Myeloma
Minsk Scientific-Practical Center for Surgery, Transplantation and HematologyP4B (60)
Showing 26 to 50 of 344 assets
PreviousPage 2 of 14Next